European Union Suspends Roche HIV Drug Due to Toxic Contamination
August 7, 2007
In an announcement today, the European Commission said it had suspended Roche's license to market its HIV drug Viracept in the European Union. The drug was withdrawn from the market in June after Roche said some batches were contaminated with ethyl mesilate, which can cause tumors. The commission said the latest action is based on the counsel of the European Medicines Agency and member nations.
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.